The conviction raises a question: Were Reuben's efforts related to Pfizer's “Operate for Cash” program, which pushed Celebrex and Bextra for unapproved ...
The jump in profits in the quarter also reflected the prior year's charges due to litigation over its pain medications Bextra and Celebrex, and from cost ...
We also led the Bextra/Celebrex multistate lawsuit, where we determined that Pfizer misrepresented the safety and efficacy of a pain killing drug for ...
... Center in Springfield, fabricated positive data on at least 21 studies of drugs, mostly painkillers such as Vioxx, Bextra and Celebrex; background here. ...
TopNews United States - Jason Ramsey - Feb 4, 2010
... or 3 cents a share, the previous year, when results were hit by a $2.3 billion legal settlement related to the marketing of the Bextra painkiller. ...
The drugs involved in the fictional studies included Merck's Vioxx and Pfizer's Celebrex and Bextra, each a member of the COX2 Inhibitor class of drugs used ...
... vezanim uz tvrtkine lijekove Bextra i Celebrex, kao i rezanje troškova, te prodaju biotehnološke jedinice Vicuron u sklopu povezivanja s Wyethom. ...
Der Entzündungshemmer Celebrex® (Celecoxib) brachte es auf 669 Millionen US-Dollar (plus 1 Prozent). Einen Rückgang um 10 Prozent auf 486 Millionen ...
Email this story
